Updated from 3:37 p.m.
Shares of Digene(DIGE Quote) were among the best-performing health-related stocks Wednesday, rising 22.6% after the company posted third-quarter earnings that easily surpassed Wall Street expectations.
Excluding items, the maker of diagnostic testing products posted earnings of $1.7 million, or 8 cents a share, on sales of $29.7 million. Analysts surveyed by Thomson First Call were expecting earnings of 4 cents a share on sales of $29 million. A year ago the company posted pro forma earnings of $1.6 million, or 8 cents a share, on sales of $23.6 million. Third-quarter results were driven by strong human papillomavirus test sales, which jumped 15% sequentially from the second quarter. Looking ahead, Digene forecast fourth-quarter earnings of 2 cents to 5 cents a share on sales of $32 million. Analysts are expecting earnings of 5 cents a share on sales of $32.2 million. Shares traded up $4.30 to $23.29. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,328.89 | 1,102.47 | 2,211.69 | 35.46 |
Oil *
73.88
|
|
UP
20.63
|
UP
6.40
|
UP
31.64
|
UP
0.59
|
10 Yr
3.55%
SPDR Gold
108.95
|
|
+0.20%
|
+0.58%
|
+1.45%
|
+1.69%
|
Data delayed 20 minutes |


Connect with TheStreet